AOCI at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s AOCI?
- Olema Pharmaceuticals, Inc. (OLMA) reported AOCI of -$460K in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s AOCI changed year-over-year?
- Olema Pharmaceuticals, Inc.'s AOCI decreased by 209.5% year-over-year, from $420K to -$460K.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s AOCI?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s AOCI has grown at a 42.9% compound annual growth rate (CAGR), from -$149K to $621K.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.